UPS has released its sixth annual "Pain in the (Supply) Chain" survey, gathering attitudes, concerns and outlooks from healthcare supply chain executives on the future of materials management.
Supply Chain
European pharmaceutical giants Novartis and GlaxoSmithKline have announced a three-part transaction worth more than $20 billion, according to a GSK news release.
The U.S. Food and Drug Administration has approved Cyramza (ramucriumab) as a treatment for patients with advanced stomach cancer and a form of cancer located where the esophagus meets the stomach.
Two hospitals — Sacred Heart in Pensacola, Fla., and St. Mary's of Michigan in Saginaw — are responsible for saving millions of dollars at their own facilities as well as a nationwide network of hospitals due to an innovative approach…
Andover, Mass.-based Philips Healthcare has temporarily stopped manufacturing CT scanners and molecular imaging equipment at its facility in Cleveland, according to a DOTmed report.
Advertisement
Lake Forest, Ill.-based Hospira has voluntarily recalled seven lots of its Propofol Injectable Emulsion, USP, citing metal particulate embedded in the interior neck of the vial as well as free-floating metal particulates found in the vials.
More than eight out of 10 high-risk devices approved through premarket approval for pediatric use were not studied in patients less than 18 years old, according to a study in Pediatrics.
Miami-based OPKO Health has entered a definitive agreement to acquire Israeli device company Inspiro Medical.
Lawrenceville, N.J.-based GS1 Healthcare US has released a guideline to help facilitate the implementation of the U.S. Food and Drug Administration's Unique Device Identifier Rule that requires medical devices to be labeled with a unique tracking code.
HealthTrust helped New Jersey-based Hackensack University Medical Center identify opportunities to save on purchased services.